Reata Pharmaceuticals Statistics, Revenue Totals, Facts & News (2022)
Last Updated on: February 27th, 2022
Here are a few of the most interesting Reata Pharmaceuticals statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Reata Pharmaceuticals Facts
- Reata Pharmaceuticals Website: Official Website
- Year Reata Pharmaceuticals was Founded: 2002
- Reata Pharmaceuticals Headquarters: Irving, TX
- Reata Pharmaceuticals Founder(s): J Warren Huff
What is Reata Pharmaceuticals?
Reata Pharmaceuticals, Inc. (Nasdaq:RETA) is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the regulation of cellular metabolism and inflammation. Reata’s two most advanced clinical candidates, bardoxolone methyl and omaveloxolone, target the important transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. (source)
Reata Pharmaceuticals Employee Count
Number of Reata Pharmaceuticals employees:
Last updated 1/1/20
Reata Pharmaceuticals Revenue Totals
Reata Pharmaceuticals annual revenue:
- 2019: $26 million
- 2018: $53 million
- 2017: $48 million
- 2016: $49 million
- 2015: $50 million
Reata Pharmaceuticals annual net income:
- 2019: $290 million net loss
- 2018: $80 million net loss
- 2017: $47 million net loss
- 2016: $6 million net loss
- 2015: $1 million net loss
Please note that some of these numbers are easier to find than others. A few of these Reata Pharmaceuticals stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.
Related Categories:
Related Tags: